Serum Cyfra 21.1 was increased from 1.87 to 5.24 ng/mL when the total tumor size of three metastatic lung nodules showed a 33% increase based on RECIST criteria, while the serum Tg and anti-TgAb levels showed minimal change (Figure 4). This evidence concerns the gene TG and neoplasm.